Histopathologic evaluation of effects of systemic Strontium Ranelate application on bone healing after grafting tibial defect
Open Access
- 4 December 2025
- journal article
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. 36 (1) , 6
Abstract
This study evaluated the effects of different doses of strontium ranelate combined with a bovine-derived deproteinized xenogeneic bone graft on bone healing in a rat defect model. Thirty-five female Sprague Dawley rats were randomly assigned to five groups (n = 7). A healthy control group received no treatment. In all other groups, a standardized 4 mm × 4 mm defect was created in the metaphyseal region of the rat tibia. The defect control group received no additional treatment. In the defect–graft group, the defect was filled with a bovine- derived deproteinized xenogeneic bone graft. In the defect– graft + strontium groups, the defect was filled with the same graft and strontium ranelate was administered by oral gavage at doses of 450 mg/kg or 900 mg/kg, three times per week for eight weeks. All rats were euthanized at the end of the eight- week experimental period. Bone tissues were harvested and processed for histological analysis. Data normality was assessed using the Shapiro–Wilk and Kolmogorov–Smirnov tests. As normality assumptions were not met, group comparisons were performed using the Kruskal–Wallis test followed by Mann– Whitney U post hoc tests. Mean horizontal defect sizes were 0 in the healthy control group, 716.86 in the defect group, 658.57 in the defect–graft group, 604.57 in the defect–graft dose 1 group, and 598.86 in the dose 2 group. Mean vertical values were 0 in the healthy group, 575.14 in the defect group, 596.43 in the defect–graft group, 569 in the dose 1 group, and 503.29 in the dose 2 group. In conclusion, strontium ranelate had a positive effect on bone healing compared to the control group, particularly when combined with grafting. A significant difference was also observed between the defect group and the high-dose group, confirming its beneficial effect on bone healing.Keywords
This publication has 37 references indexed in Scilit:
- Comparison of Bovine and Porcine Collagen Membranes for Potential Applications in Guided Bone Regeneration: An In Vivo Pre‐Clinical EvaluationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2025
- The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regenerationActa Biomaterialia, 2017
- Local drug delivery for enhancing fracture healing in osteoporotic boneActa Biomaterialia, 2015
- The potential restorative effects of strontium-doped bioactive glass on bone microarchitecture after estrogen-deficieny induced osteoporosis: Physicochemical and histomorphometric analysesJournal of the Korean Society for Applied Biological Chemistry, 2013
- Osteogenic potential of Sr‐doped calcium phosphate hollow spheres in vitro and in vivoJournal of Biomedical Materials Research Part A, 2013
- The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activationMolecular and Cellular Biochemistry, 2011
- How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosisOsteoporosis International, 2010
- Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin responseOsteoporosis International, 2008
- The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferationBiochemical Pharmacology, 2007
- Induction of a program gene expression during osteoblast differentiation with strontium ranelateBiochemical and Biophysical Research Communications, 2007